Diabetes is potentially fatal when unmanaged by medication — CVS Caremark designed a program to ensure cost isn’t a barrier to treatment.
People living with diabetes typically spend around $467 out-of-pocket for brand name prescriptions every year, according to a CVS Caremark study. A small segment of those patients (12%) spend up to $1,000 on diabetes medications. CVS executives say their new RxZERO program, announced today, provides these medications without raising costs for employers or their workforce.
